As a pharmaceuticals manufacturer, Duopharma Biotech seeks to minimise as far as possible any negative footprint we have while putting in place systems and processes to create positive outcomes. Our Climate Performance-related initiatives cover carbon emissions and energy usage reduction, improving water management efficiency as well as reduction in waste generation.
The greenhouse gases (GHG) emitted by human activities have contributed to global warming and climate change such as intense droughts, rising sea levels, flooding and catastrophic storms, amongst others. At Duopharma, we constantly reviewing our mechanism to track and report GHG emissions (i.e. carbon emissions), and move towards carbon neutral pathway. To support this, we have set target to offset 10% of Scope 2 carbon emissions annually. In the long term, we aim to achieve Carbon Neutrality by 2030 and Net Zero Carbon Emissions by 2050.
Anchored by our 5-year ESG Strategy, we look at multiple ways to reduce our carbon emissions and energy consumption. Our Climate Roadmap outlines potential carbon and energy reduction initiatives that we plan to embark in the short, medium and long-term, and help us to strategise and prioritise our mitigation actions accordingly. This includes exploring renewable energy opportunities and implementing alternative clean energy i.e. Solar, Cooling, Heat & Power (CHP) for all sites to reduce emissions in the near future.
Water is a pressing need in many areas of the world. Water scarcity may impose high risk to operations as water is needed to grow and process food, create energy, and serve industry for a continually growing population. At Duopharma, we believe the importance of comprehensive water management, which is managed through monitoring of water consumption, implementing water efficiency initiatives and proper management of effluents and wastewater to protect water resources.
At Duopharma, we believe the importance of comprehensive water management. We established water management plan for all three main manufacturing sites in Klang, Bangi and Glenmarie. The water management plan includes guidelines and procedures to monitor water consumption and recyling, proper management of effluents and wastewater (monitoring of effluent characteristics), and the implementation of water efficiency initiatives. The outcome of the monitoring (water usage and quality) are presented to the Management Committee on monthly basis, whereas effluent characteristics are presented to Environmental Performance Monitoring Committee (EPMC) every quarter.
When waste is disposed of or recycled in a safe, ethical, and responsible manner, it helps reduce the negative impacts to the environment. Ensuring that waste and material management procedures are carried out responsibly and with regularity helps to avoid unnecessary waste generation. At Duopharma, we strive to ensure efficient use of materials, adopt best practices in waste disposal, strengthening our recycling efforts and ensuring compliance to relevant environmental laws and regulations throughout our operations.
We recognise the increasing urgent attention to manage climate-related risks throughout our activities and operations. We have put in place climate-related risk management measures to properly assess and adapt to those risks. This includes the requirement to assess any new project on climate-related risks and impacts, prior to its approval and commencement. We have also identified climate-related risks (physical and transitional risk) relevant to our operations, which were subsequently included in Enterprise Risk Management (ERM) for close monitoring and mitigation. Our Board of Directors also provide oversight over climate change in their decision-making processes, where ESG/climate-related risks are included as one of the assessment requirement.